Recruiting studies: Pediatric Plaque Psoriasis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis
Phase 4 · 9 location(s) · Bausch Health Americas, Inc. · NCT03987763 A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With
Phase 3 · 63 location(s) · Bristol-Myers Squibb · NCT04772079 Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cose
Phase N/A · 1 location(s) · Novartis Pharmaceuticals · NCT07243782 A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Ye
Phase 3 · 50 location(s) · UCB Biopharma SRL · NCT06425549 A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
Phase 3 · 40 location(s) · Takeda · NCT07250802

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.